Northern Ireland Women Face HRT Shortages: Estradot and FemSeven Conti Affected

Women across Northern Ireland are confronting shortages of critical Hormone Replacement Therapy (HRT) products, prompting concerns about access to essential medication. Two particular brands, Estradot transdermal patches and FemSeven Conti patches, have been identified as having significant supply disruptions.

Health authorities have responded by issuing advice to women currently using these products. The guidance focuses on potential alternative treatments and strategies to manage the disruption, though specific details on the duration of these shortages remain unclear. The unavailability of these HRT products underscores the fragility of pharmaceutical supply chains and their direct impact on patient well-being.

This situation highlights ongoing challenges within the healthcare system to ensure consistent access to necessary medications, especially those crucial for managing chronic conditions. Patients are advised to consult their General Practitioner or pharmacist for personalised guidance on managing their HRT regimen amidst these supply issues.